CYP19A1 and polycystic ovary syndrome: They reported marked inhibition of aromatase activity in granulosa cells from normal ovary in comparison to granulosa cells from polycystic ovaries with lower minimal effective dose of the inhibitor and higher inhibitory effect in normal ovaries suggesting that there was a higher basal aromatase activity in PCOS.